New Zealand markets closed

MiNK Therapeutics, Inc. (INKT)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.9600-0.0300 (-3.03%)
At close: 04:00PM EDT
0.9500 -0.02 (-2.06%)
Pre-market: 07:37AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-20,585
-22,458
-27,991
-30,213
-16,239
-
Depreciation & amortisation
212.762
204.617
121.749
77.96
55.06
-
Stock-based compensation
3,531
3,860
3,027
1,745
87.829
-
Change in working capital
3,165
2,897
8,767
3,736
-324.932
-
Accounts payable
-2,496
-1,918
2,661
-152.042
607.855
-
Other working capital
-13,998
-15,836
-19,117
-13,076
-8,433
-
Other non-cash items
-
-
-2,791
12,182
8,083
4,486
Net cash provided by operating activities
-13,938
-15,763
-18,867
-12,827
-8,338
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-73.561
-250.046
-248.983
-95.212
-
Net cash used for investing activities
-60.061
-73.561
-250.046
-248.983
-95.212
-
Cash flows from financing activities
Common stock issued
-
-
0
39,797
0
-
Common stock repurchased
-97.718
-477.639
-157.194
0
-
-
Net cash used provided by (used for) financing activities
4,934
-407.173
-155.599
49,257
11,106
-
Net change in cash
-9,075
-16,268
-19,253
36,198
2,392
-
Cash at beginning of period
14,892
19,636
38,889
2,691
299.036
-
Cash at end of period
5,828
3,367
19,636
38,889
2,691
-
Free cash flow
Operating cash flow
-13,938
-15,763
-18,867
-12,827
-8,338
-
Capital expenditure
-
-73.561
-250.046
-248.983
-95.212
-
Free cash flow
-13,998
-15,836
-19,117
-13,076
-8,433
-